NCT03136731View on ClinicalTrials.gov

Evidence-based Screening Strategies for Celiac Disease

Enrolling by invitationOBSERVATIONAL
Enrollment

3,517

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2032

Conditions
Celiac Disease
Interventions
DIAGNOSTIC_TEST

Celiac disease antibody screening

Observational parameters

Trial Locations (1)

33521

Tampere University Hospital / Tampere University, Tampere

All Listed Sponsors
lead

Katri Kaukinen

OTHER